Company Filing History:
Years Active: 2022
Title: Kelli-Ann Monaco: Innovator in Cancer Treatment
Introduction
Kelli-Ann Monaco is a prominent inventor based in Medford, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical combinations.
Latest Patents
Kelli-Ann Monaco holds 1 patent for her invention titled "Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers." This invention relates to a pharmaceutical combination comprising an MDM2 inhibitor and an ERK inhibitor, aimed at treating various cancers. The patent outlines the uses of this combination for preparing a medicament, methods of treating cancer in subjects, and the formulation of pharmaceutical compositions.
Career Highlights
Kelli-Ann Monaco is associated with Novartis AG, a leading global healthcare company. Her work focuses on developing innovative solutions for cancer treatment, showcasing her commitment to advancing medical science.
Collaborations
Throughout her career, Kelli-Ann has collaborated with notable professionals in her field, including Giordano Caponigro and Ensar Halilovic. These collaborations have contributed to her success and the advancement of her research.
Conclusion
Kelli-Ann Monaco is a trailblazer in the field of cancer treatment, with her innovative patent reflecting her dedication to improving patient outcomes. Her work continues to inspire advancements in medical research and pharmaceutical development.